Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Medipost, Inc.

Clinical trials sponsored by Medipost, Inc., explained in plain language.

Medipost, Inc. 078160 KOSDAQ

A Korean biotech specializing in stem cell therapies.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1 Completed 1

Stem cell gel could offer new hope for knee arthritis sufferers

Disease control Recruiting now

This Phase 3 trial tests whether a gel made from donated umbilical cord stem cells (CARTISTEM) can reduce pain and improve knee function better than a simple surgical cleanup (debridement) in people with knee cartilage damage and osteoarthritis. About 300 adults aged 18-75 with m…

Phase: PHASE3 • Sponsor: Medipost, Inc. • Aim: Disease control

Last updated Aug 08, 2026 00:03 UTC